Stemcell Treatment
Overview
F A Qs
Links

SUCCESSFUL CASES
Chronic Limb Ischemia
Spinal Cord Injury
Ischemic Heart Diseases
Cirrhosis of Liver



In The News

 
 

Links

Stem cell therapy for Spinal Cord Injury
Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients.

Strategies to create a regenerating environment for the injured spinal cord

Stem and progenitor cell-based therapy of the human central nervous system

Regeneration following spinal cord injury, from experimental models to humans: where are we?

A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study

Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor

Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial

Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up

Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies


Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients


Stem cell therapy for Cirrhosis of Liver

Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.

Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis

Autologous Bone Marrow stem cell Infusion (AMBI) therapy for Chronic Liver Diseases.


Stem cell therapy for Ischemic Heart diseases
ICell sources for cardiac regeneration--which cells and why

Stem cell therapy for ischemic heart disease: beginning or end of the road?

Application of stem cell technology for coronary artery disease at the All India Institute of Medical Sciences, New Delhi, India

Intramyocardial delivery of bone marrow mononuclear cells and mechanical assist device implantation in patients with end-stage cardiomyopathy

Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up

Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial.

intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke


Intramyocardial angiogenic cell precursors in nonischemic dilated cardiomyopathy

Efficacy of Intramyocardial Injection of Angiogenic Cell Precursors for Ischemic Cardiomyopathy A Case Match Study

Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function

Autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting in patients with ischemic cardiomyopathy.

Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting

Intramyocardial injection of autologous bone marrow cells as an adjunctive therapy to incomplete myocardial revascularization--safety issues

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

Stem cell therapy for Peripheral Vascular Diseases
Therapeutic angiogenesis by autologous bone marrow cell implantation together with allogeneic cultured dermal substitute for intractable ulcers in critical limb ischaemia

The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation

Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

Critical limb ischemia and stem cell research: anchoring hope with informed adverse event reporting

Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells

Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia

Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia

Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature

Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia

Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal

Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study